435 related articles for article (PubMed ID: 14973393)
1. The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors.
Edwards DP
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):307-24. PubMed ID: 14973393
[TBL] [Abstract][Full Text] [Related]
2. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
[TBL] [Abstract][Full Text] [Related]
3. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.
Ma H; Hong H; Huang SM; Irvine RA; Webb P; Kushner PJ; Coetzee GA; Stallcup MR
Mol Cell Biol; 1999 Sep; 19(9):6164-73. PubMed ID: 10454563
[TBL] [Abstract][Full Text] [Related]
4. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
5. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
7. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators.
Demarest SJ; Martinez-Yamout M; Chung J; Chen H; Xu W; Dyson HJ; Evans RM; Wright PE
Nature; 2002 Jan; 415(6871):549-53. PubMed ID: 11823864
[TBL] [Abstract][Full Text] [Related]
8. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
9. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain.
Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH
Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037
[TBL] [Abstract][Full Text] [Related]
10. Use of suppressor mutants to probe the function of estrogen receptor-p160 coactivator interactions.
Mak HY; Parker MG
Mol Cell Biol; 2001 Jul; 21(13):4379-90. PubMed ID: 11390665
[TBL] [Abstract][Full Text] [Related]
11. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators.
Stallcup MR; Kim JH; Teyssier C; Lee YH; Ma H; Chen D
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):139-45. PubMed ID: 12943698
[TBL] [Abstract][Full Text] [Related]
12. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes.
Rachez C; Gamble M; Chang CP; Atkins GB; Lazar MA; Freedman LP
Mol Cell Biol; 2000 Apr; 20(8):2718-26. PubMed ID: 10733574
[TBL] [Abstract][Full Text] [Related]
13. The SRC family of nuclear receptor coactivators.
Leo C; Chen JD
Gene; 2000 Mar; 245(1):1-11. PubMed ID: 10713439
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and NMR mapping of the interface between CREB-binding protein and ligand binding domains of nuclear receptor: beyond the LXXLL motif.
Klein FA; Atkinson RA; Potier N; Moras D; Cavarelli J
J Biol Chem; 2005 Feb; 280(7):5682-92. PubMed ID: 15542861
[TBL] [Abstract][Full Text] [Related]
15. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B
Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556
[TBL] [Abstract][Full Text] [Related]
16. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
17. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.
Jaber BM; Mukopadhyay R; Smith CL
J Mol Endocrinol; 2004 Feb; 32(1):307-23. PubMed ID: 14766010
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights into nuclear receptor signaling.
Jin L; Li Y
Adv Drug Deliv Rev; 2010 Oct; 62(13):1218-26. PubMed ID: 20723571
[TBL] [Abstract][Full Text] [Related]
20. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
